AI assistant
Sending…
ORACLE CORP — Director's Dealing 2014
Dec 24, 2014
29742_dirs_2014-12-24_b7e19483-09a8-4166-8e1f-13d1df8a09db.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2014-12-22
Reporting Person: Kurian Thomas (EVP-Product Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-22 | Common Stock | M | 1000000 | $32.43 | Acquired | 1032958 | Direct |
| 2014-12-22 | Common Stock | M | 500000 | $29.72 | Acquired | 1532958 | Direct |
| 2014-12-22 | Common Stock | M | 1000000 | $30.11 | Acquired | 2532958 | Direct |
| 2014-12-22 | Common Stock | S | 2500000 | $45.7251 | Disposed | 32958 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-22 | Stock Option | $32.43 | M | 1000000 | Disposed | 2021-06-29 | Common Stock (1000000) | Direct |
| 2014-12-22 | Stock Option | $29.72 | M | 500000 | Disposed | 2022-07-05 | Common Stock (500000) | Direct |
| 2014-12-22 | Stock Option | $30.11 | M | 1000000 | Disposed | 2023-07-01 | Common Stock (1000000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $45.50 to $45.9950. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Option vests 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2